An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer

Yue Kuai(Sir Run Run Shaw Hospital), Weidong Han(Chinese PLA General Hospital)
Theranostics
January 1, 2020
Cited by 36


Related Papers